Zoetis Inc (ZTS)
$76.81-1.30%
Spriggl Score: Good— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Quality animal health franchise at a cyclical low; litigation risk and generic pressure make Q2 results pivotal.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Zoetis Inc
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally…
- Sector:
- Healthcare
- Industry:
- Drug Manufacturers - Specialty & Generic
- Market Cap:
- $33.0B
Recent dividends
- 20 Jul 2026$0.53
- 20 Apr 2026$0.53
- 20 Jan 2026$0.53
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Zoetis Inc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free